One-Year Clinical and Real-World Outcomes with the TENEO Excimer

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/fd/65/3a/fd653a11-faed-f84f-7c6f-758a758f4f1a/mza_7682981912169602537.jpg/600x600bb.jpg

CRST: The Podcast

Cataract and Refractive Surgery Today

151 episodes

1 week ago

Join CRST: The Podcast at the intersection of patient care and innovation in ophthalmology and listen as experts in the field engage in thought-provoking discussion on anterior segment surgery. This podcast curates content and mini series that help progressive cataract and refractive surgeons take their practices to the next level. CRST: The Podcast is produced by Bryn Mawr Communications and the medical trade publication Cataract & Refractive Surgery Today.

All content for CRST: The Podcast is the property of Cataract and Refractive Surgery Today and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Technology

Science,

Life Sciences

One-Year Clinical and Real-World Outcomes with the TENEO Excimer

CRST: The Podcast

37 minutes

4 months ago

One-Year Clinical and Real-World Outcomes with the TENEO Excimer

In this episode, Drs. Waring and Chu share clinical insights and real-world experience from the first year of using the Teneo 317 excimer laser for correcting myopia and myopic astigmatism. As the first excimer platform to receive FDA approval in over 15 years, the Teneo 317 introduces modern performance to U.S. practices with its compact design, fast ablation speed, and intuitive user interface. The conversation covers key findings from the FDA clinical trial and early post-market use, including exceptional visual acuity outcomes, improved night vision, and high levels of patient satisfaction. Sponsored by Bausch + Lomb©2025 Bausch + Lomb TEN.0014.USA.25